Rebecca Sutphen on the Importance of Connecting Patients With Clinical Trials

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lisa Schlager, from FORCE, about the types of legal protections in place for those with a genetic risk for cancer.

One expert explains why double autologous stem cell transplantation is a viable alternative to back-to-back transplant in high-risk multiple myeloma.

This week, we spoke with FORCE to dispel some of the misconceptions associated with at-home genetic testing for hereditary cancer risk.

An expert explained that patients with breast cancer who undergo genetic testing may help their family members, regardless of whether patients have children.

An expert discusses three crucial conversations about cancer care that patients should have with their health care providers.